CSF testing demonstrated normal p-tau in a subset of participants (24% in our cohort), and FDG–PET commonly demonstrated significant frontal hypometabolism (Fig. 7), which can be misidentified as frontotemporal dementia. The gene discussed is MAPT; the disease is frontotemporal dementia.